NephCure Kidney International ® – Saving Kidneys, Saving Lives

Everything You Need to Know About Travere’s New Clinical Trial for Children, EPPIK

September 2, 2021 By Kylie Winkler 3 Comments

Travere Therapeutics has recently launched their Phase 2 pediatric clinical trial, EPPIK (Evaluating Problematic Proteinuria in Kids) which is aimed at helping children with FSGS, MCD, IgAN and other rare kidney diseases. We know that with a clinical study specifically designed for kids, parents and caregivers may have some questions. We asked Travere to answer […]

Kidney-Friendly Recipe: Italian Herb Grilled Chicken with Grilled Veggies and Quinoa

September 1, 2021 By Kylie Winkler Leave a Comment

As kids head back to school and the long summer nights slowly slip away, celebrate the end of the season with a delicious meal on the grill– perfect for Labor Day Weekend! This recipe comes from NephCure’s Chef Sachet, a patient parent whose 12-year-old son Aiden was diagnosed with FSGS in January 2017. Aiden’s kidney disease […]

Get to Know Dr. Matt Sampson

August 26, 2021 By Delaney Geraghty Leave a Comment

NephCure is proud to honor Dr. Matthew Sampson as our 2021 Boston Countdown to a Cure Medical Honoree, recognizing his outstanding contributions to nephrology and the NephCure community. Dr. Sampson is a Pediatric Nephrologist at Boston Children’s Hospital and holds the Warren E. Grupe Endowed Chair in Nephrology. He is also an Associate Professor of […]

Encouraging interim results from Travere’s PROTECT trial for IgAN patients

August 20, 2021 By Kylie Winkler

Interim results have been announced from Travere Therapeutic’s PROTECT study, and although preliminary, the data look promising for IgA Nephropathy (IgAN) patients. Travere’s ongoing Phase 3 trial is studying the drug sparsentan in IgAN patients. On average, patients who received sparsentan experienced a nearly 50% reduction of proteinuria after 36 weeks. That’s roughly three times […]